Bacterial cell fate under stress: lipid remodeling and antimicrobial peptide attack
Devi, N. S. et al. Overview of antimicrobial resistance and mechanisms: The relative status of the past and…
Novo Nordisk launches Wegovy subscription for GLP-1 obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a…
Health care giants are trimming jobs, not driving employment growth
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Natural peptide in sweat may help block flu infection before symptoms start
A naturally produced peptide found in sweat, saliva, tears, and the nasopharynx may help stop influenza before it…
Lab-grown food pipe offers hope for children with esophageal conditions
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus…
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
Molecular Adaptations And Engineering Of Extremophiles For Synthetic Biology And Biotechnological Applications
Industrial applications and role in the climate change of different classes of extremophiles. (a) Illustrations in the inner…
Tricorder Tech: Protein Sequencing Advance Offers New Insights Into Life’s Foundations
DNA-encoded Edman degradation on magnetic beads. (A) Reaction scheme for barcoding PTC amino acids via DNA-encoded Edman degradation…
Defining the limits of immunotherapy in early small-cell lung cancer
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
TrumpRx: High expectations, but limited impact a month after launch
WASHINGTON — President Trump heralded his signature drug discount platform, TrumpRx, as “one of the most transformative health…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…